Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 6/20 | 0.63 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.63 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.52 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28661202 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 | |
| SCHEMBL10804885 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 | |
| SCHEMBL11629828 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 | |
| SCHEMBL5102963 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 | |
| SCHEMBL11437074 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 | |
| SCHEMBL4390623 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 | |
| SCHEMBL6757021 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 | |
| SCHEMBL5419098 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 | |
| SCHEMBL22660994 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 | |
| SCHEMBL28600792 | 1.00 | S1PR2 (0.63) | S1PR2S1PR1GPR84ALDH1A1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270567-A1 | GENERATION OF ACYL AMINO ACIDS | MODULAR GENETICS INC (US) | 2025-08-28 | — | — | US | disclosed |
| US-12123004-B2 | Generation of acyl amino acids | MODULAR GENETICS, INC. (US) | 2024-10-22 | — | — | US | disclosed |
| US-12031167-B2 | Generation of acyl amino acids | MODULAR GENETICS, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| CN-113774033-B | Artificial biocatalyst for converting fatty acid into beta-hydroxy fatty acid | 合肥生融生物科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20220259626-A1 | GENERATION OF ACYL AMINO ACIDS | MODULAR GENETICS, INC. | 2022-08-18 | — | — | US | disclosed |
| CN-113774033-A | Artificial biocatalyst for converting fatty acid into beta-hydroxy fatty acid | 合肥生融生物科技有限公司 | 2021-12-10 | — | — | CN | disclosed |
| US-11155843-B2 | Generation of acyl amino acids | MODULAR GENETICS, INC. (US) | 2021-10-26 | — | — | US | disclosed |
| CN-110536977-B | Copper colloidal catalyst solution for electroless copper plating, electroless copper plating method, and method for producing copper-plated substrate | 石原化学株式会社 | 2021-08-17 | — | — | CN | disclosed |
| US-20210062234-A1 | GENERATION OF ACYL AMINO ACIDS | MODULAR GENETICS, INC. | 2021-03-04 | — | — | US | disclosed |
| US-10640799-B2 | Generation of acyl amino acids | MODULAR GENETICS, INC. (US) | 2020-05-05 | — | — | US | disclosed |
| US-7938948-B2 | Silver and silver alloy plating bath | ISHIHARA CHEMICAL CO., LTD. (JP) | 2011-05-10 | — | — | US | disclosed |
| US-20090321269-A1 | SILVER AND SILVER ALLOY PLATING BATH | ISHIHARA CHEMICAL CO., LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20090301998-A1 | METHOD OF FORMING NOZZLE HOLE AND METHOD OF MANUFACTURING INKJET RECORDING HEAD | FUJIFILM CORPORATION (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20090294295-A1 | METHOD FOR FORMING COMPOSITE PLATING FILM AND PROCESS FOR MANUFACTURING INKJET RECORDING HEAD | FUJIFILM CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090293277-A1 | PROCESS FOR MANUFACTURING LAMINATED STRUCTURE AND PROCESS FOR MANUFACTURING INKJET RECORDING HEAD | FUJIFILM CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| EP-0488668-A1 | Foam-forming herbicidal composition and method of application | FUMAKILLA LIMITED (JP) | 1992-06-03 | — | — | EP | disclosed |
| US-4933465-A | Magenta coupler | CHEIL SYNTHETIC TEXTILE CO., LTD. (KR) | 1990-06-12 | — | — | US | disclosed |
| US-4230788-A | Method of manufacturing an external electrically conducting metal pattern | U.S. PHILIPS CORPORATION (US) | 1980-10-28 | — | — | US | disclosed |
| US-4045335-A | FROTH FLOTATION | DUVAL CORPORATION (US) | 1977-08-30 | — | — | US | disclosed |
| US-3960564-A | Physical development process utilizing a physical developer containing a specific reducing agent, a thiol compound | U.S. PHILIPS CORPORATION (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10640799-B2 | Generation of acyl amino acids | FADS1, FADS2, COASY | S1PR2 2907/4885S1PR1 2579/4885GPR84 899/4885 |
| US-20220259626-A1 | GENERATION OF ACYL AMINO ACIDS | FADS1, FADS2, FAR1 | S1PR2 3456/4885S1PR1 3106/4885GPR84 770/4885 |
| US-12031167-B2 | Generation of acyl amino acids | FADS1, FADS2, FAR1 | S1PR2 3456/4885S1PR1 3106/4885GPR84 770/4885 |
| US-20210062234-A1 | GENERATION OF ACYL AMINO ACIDS | FADS1, FADS2, COASY | S1PR2 2907/4885S1PR1 2579/4885GPR84 899/4885 |
| US-11155843-B2 | Generation of acyl amino acids | FADS1, FADS2, COASY | S1PR2 2907/4885S1PR1 2579/4885GPR84 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.